Skip to main content
. 2015 Mar 27;10(3):e0121822. doi: 10.1371/journal.pone.0121822

Fig 1. Overall survival (A), progression-free survival (B) and disease free survival (C) in the whole cohort according to histologic subgroup.

Fig 1

Overall survival according to primary treatment response (E). ALCL: anaplastic large cell lymphoma; ALK: anaplastic large cell lymphoma kinase; CR: complete remission; PR: partial remission; NR: no response, including stable and progressive disease.